Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gold Flora was a leading vertically integrated cannabis operator in California with over $100 million annual revenue at its peak. The company owned indoor cultivation facilities totaling approximately 107,000 square feet across multiple sites; operated manufacturing/extraction facilities; distributed both proprietary and third-party brands statewide; and managed a portfolio of dispensaries under various banners. In March 2025 it entered voluntary receivership due to inherited liabilities from its business combination with The Parent Company (TPCO), resulting in halted trading and an impending asset sale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gold Flora.